FAVOURABLE EFFECTS OF TIRZEPATIDE IN NASH & RAISED ADIPONECTIN IN T2DM

Dear my friends and fellow Colleagues, Here is an update on TIRZEPATIDE. Higher doses of Tirzepatide (Novel Dual GIP and GLP-1 Receptor Agonist) significantly decreased NASH-related biomarkers and increased adiponectin in patients with T2DM. (Hartman ML et al, Diabetes Care. 2020 Jun;43(6):1352-1355) Regards and thanks, Dr Sepuri Krishna Mohan.

3 Likes

LikeAnswersShare
Ur updates are awesome
Rosiglitazone
Yes, especially Pioglitazone is associated with reduced incidence of NAFLD/NASH. Like wise it's useful in PCOS too and is now the recommended drug of Choice for PCOS.
0

Cases that would interest you